CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
批准号:
6778160
负责人:
Sewon Kang
金额:
$12.31万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-08-21 至 2006-01-31
关键词:
acneagingantioxidantsburn therapyclinical researchclinical trialscollagenfibrosisfree radical oxygenhealth science researchhuman subjecthuman therapy evaluationimmunotherapyinterleukin 10keloid skin disordermedical educationphototherapypsoriasisradiation dosagerole modelscarssclerodermaskin disordertrainingultraviolet therapy
中文摘要
该申请是为了响应面向患者研究的中期职业研究者奖(PA-98-053),该奖项旨在支持年轻、活跃和成功的临床研究者克服面向患者研究的一些主要障碍:时间、资源和指导。姜世元博士就是这样一位经过多年专业训练并致力于指导下一代临床研究者的临床研究者。该计划的目标是进一步建立候选人独立的以患者为导向的临床研究计划,特别是在临床转化研究方面,并为他提供必要的时间和资源来指导实习生进行皮肤临床研究。该项目的活动领域是Kang博士的研究计划,重点是在纤维化皮肤病中使用紫外线(UV)-A1辐射进行治疗,在体内与人体皮肤光老化相关的紫外线信号中抗氧化剂的作用,白介素-10在牛皮癣中的作用,以及他指导初级临床研究人员的计划。除了在合理的研究设计、执行和分析方面更传统的培训途径之外,这三个项目还为临床研究人员提供了一个新的培训途径,使他们能够使用可重复观察和可靠记录与人类疾病有关的分子现象所需的工具。该候选人具有指导博士前和博士后学员的良好记录。康博士的研究项目将为他继续培训初级临床调查员提供背景。他的研究和指导项目将得到密歇根大学优秀临床研究和培训项目的支持。其中包括最近授予的机构课程,向年轻的实习生和初级教师(K-30)教授临床研究的基本知识,一个资金充足的普通临床研究中心,临床调查和治疗中心,临床研究设计和统计分析教育计划,以及公共卫生学院。总之,候选人在以患者为导向的研究方面的专业知识和成就,他指导初级临床研究者的能力和承诺,以及密歇根大学的研究和培训优势,共同为实现本提案的具体目标提供了理想的环境。
英文摘要
This application is in response to the Mid-career Investigator Award in Patient-Oriented Research (PA-98-053) which was created to support young, active and successful clinical investigators to overcome some of the major barriers to patient-oriented research: time, resource and mentoring. Dr. Sewon Kang represents such a clinical researcher with years of specialty training and commitment to mentoring the next generation of clinical investigators. The objectives of this program are to further establish the candidate's independent patient-oriented clinical research program, especially in clinical translational research, and to provide him the time and resources necessary to mentor trainees pursuing clinical investigations in skin. The areas of activity of this project are Dr. Kang's research plan focused on therapeutic use of ultraviolet (UV)-A1 radiation in fibrosing skin diseases, effects of antioxidants in UV-signaling relevant to photoaging in human skin in vivo, and interleukin-10 in psoriasis, along with his plans for mentoring beginning clinical investigators. The three projects allow, in addition to the more traditional avenue of training in sound study design, execution, and analysis, opportunities for a novel avenue for training of clinical investigators to use tools required for reproducible observation and reliable documentation of molecular phenomenon relevant to human disease. The candidate has an established record of providing mentorship to pre- and post-doctoral trainees. Dr. Kang's research program will provide the context for him to continue to train beginning clinical investigators. His research and mentoring programs will be supported by the outstanding clinical research and training programs of the University of Michigan. These include the recently awarded institutional curriculum to teach the essentials of clinical research to young trainees and junior faculty (K-30), a well- funded General Clinical Research Center, the Center for Clinical Investigation and Therapeutics, educational program in Clinical Research Design and Statistical Analysis, and the School of Public Health. In summary, the candidate's expertise and accomplishments in patient-oriented research, his ability and commitment to mentor beginning clinical investigators, and the research and training strengths of the University of Michigan combine to provide an ideal context to accomplish the specific aims of this proposal.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Retinoic acid 4-hydroxylase inducibility and clinical response to isotretinoin in patients with acne.
痤疮患者的视黄酸 4-羟化酶诱导能力和对异维A酸的临床反应。
DOI:
10.1016/j.jaad.2009.03.013
发表时间:
2009
期刊:
Journal of the American Academy of Dermatology
影响因子:
13.8
作者:
[Wang,Frank, Kwak,HehShinR, Elbuluk,Nada, Kaczmarek,AnyaL, Hamilton,Ted, Voorhees,JohnJ, Fisher,GaryJ, Kang,Sewon]
通讯作者:
Kang,Sewon
P3: Infrared Irradiation and Scleroderma Skin
-
批准号:7483078
-
项目类别:
-
资助金额:$3.69万
-
财政年份:2007
-
负责人:Sewon Kang
-
依托单位:
OPEN LABEL STUDY OF TETRATHIOMOLYBDATE IN TREATMENT OF PSORIASIS VULGARIS
-
批准号:7199915
-
项目类别:
-
资助金额:$0.67万
-
财政年份:2005
-
负责人:Sewon Kang
-
依托单位:
Univ of Michigan Multidisciplinary Clinical Resea**(RMI)
-
批准号:7050494
-
项目类别:
-
资助金额:$67.14万
-
财政年份:2005
-
负责人:Sewon Kang
-
依托单位:
University of Michigan Multidisciplinary Clinical Research (RMI)
-
批准号:7288723
-
项目类别:
-
资助金额:$17.63万
-
财政年份:2005
-
负责人:Sewon Kang
-
依托单位:
University of Michigan Multidisciplinary Clinical Research (RMI)
-
批准号:7169521
-
项目类别:
-
资助金额:$67.03万
-
财政年份:2005
-
负责人:Sewon Kang
-
依托单位:
UV-induced collagen reduction: treating skin scleroderma
-
批准号:6789958
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2001
-
负责人:Sewon Kang
-
依托单位:
UV-Induced Collagen Reduction--Treating Skin Scleroderma
-
批准号:6407566
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2001
-
负责人:Sewon Kang
-
依托单位:
UV-induced collagen reduction: treating skin scleroderma
-
批准号:6512141
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2001
-
负责人:Sewon Kang
-
依托单位:
UV-induced collagen reduction: treating skin scleroderma
-
批准号:6915175
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2001
-
负责人:Sewon Kang
-
依托单位:
UV-induced collagen reduction: treating skin scleroderma
-
批准号:6605012
-
项目类别:
-
资助金额:$37.75万
-
财政年份:2001
-
负责人:Sewon Kang
-
依托单位:
CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
-
批准号:6532924
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2000
-
负责人:Sewon Kang
-
依托单位:
CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
-
批准号:6085893
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2000
-
负责人:Sewon Kang
-
依托单位:
CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
-
批准号:6374353
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2000
-
负责人:Sewon Kang
-
依托单位:
CLINICAL TRANSLATIONAL RESEARCH IN DERMATOLOGY
-
批准号:6650380
-
项目类别:
-
资助金额:$12.31万
-
财政年份:2000
-
负责人:Sewon Kang
-
依托单位:
ABX IL8 IN TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS
-
批准号:6263685
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:Sewon Kang
-
依托单位:
ABX IL8 IN TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS
-
批准号:6297042
-
项目类别:
-
资助金额:$0.02万
-
财政年份:1998
-
负责人:Sewon Kang
-
依托单位:
BG9273 (LFA3/IGG1 FUSION PROTEIN) IN PATIENTS WITH CHRONIC PSORIASIS
-
批准号:6274783
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:Sewon Kang
-
依托单位:
SAFETY AND EFFICACY OF ORAL RAPAMYCIN IN THE TREATMENT OF RECALCITRANT PSORIASIS
-
批准号:6244611
-
项目类别:
-
资助金额:$2.22万
-
财政年份:1997
-
负责人:Sewon Kang
-
依托单位:
STUDY OF HU1124 IN MODERATE TO SEVERE PLAQUE PSORIASIS
-
批准号:6274759
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:Sewon Kang
-
依托单位:
PHASE I STUDY OF BMS188667 (CTLA4IG) IN PATIENTS WITH PSORIASIS VULGARIS
-
批准号:6274648
-
项目类别:
-
资助金额:$2.15万
-
财政年份:1997
-
负责人:Sewon Kang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
HIF-1α调控软骨细胞衰老在骨关节炎进展中的作用及机制研究
-
批准号:82371603
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈晓
-
依托单位:
间皮细胞衰老在腹膜透析后腹膜适应不良修复和纤维化发病中的作用及机制研究
-
批准号:82370743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姜娜
-
依托单位:
衰老抑制脊髓损伤修复的CXCL13依赖性CD8+T细胞通讯机制研究
-
批准号:82371585
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:周鲁明
-
依托单位:
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
-
批准号:82370774
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮渊
-
依托单位:
LMNA基因R527C纯合突变儿童早老症干细胞功能异常及分子机理研究
-
批准号:32100603
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:周焱
-
依托单位:
SIRT2在灵长类心肌衰老进程中的作用及其机制研究
-
批准号:32000510
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:范艳玲
-
依托单位:
NRF2/MFN2/ERS信号异常促进ADSCs衰老和肥大型肥胖皮下脂肪组织胰岛素抵抗的机制研究
-
批准号:32000511
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:方佳
-
依托单位:
隐性遗传方式儿童早老症患者SASP-like炎症反应病理特征和分子机制研究
-
批准号:32060157
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:舒伟
-
依托单位:
c-Fos在皮肤上皮干细胞衰老中的作用研究
-
批准号:32070730
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:张亮
-
依托单位:
SETD8介导H4K20单甲基化修饰对MSCs抗衰老的作用机制
-
批准号:32060156
-
项目类别:地区科学基金项目
-
资助金额:36.0万元
-
批准年份:2020
-
负责人:刘鹏霞
-
依托单位: